ARK Genomic Revolution ETF (ARKG)
Cboe BZX · ETF
$38.28-3.99%
As of Jul 20, 2026
Price history
Key statistics
- Market cap
- $1.35B
- Volume
- 3,988,038
- 52-week high
- —
- 52-week low
- —
- Open
- $39.58
- Day high
- $39.66
- Day low
- $38.19
Top holdings
| Holding | Name | Weight |
|---|---|---|
| TWST | Twist Bioscience Corp | 9.15% |
| TEM | Tempus AI Inc Class A common stock | 7.64% |
| ABSI | Absci Corp | 7.01% |
| TXG | 10x Genomics Inc Ordinary Shares - Class A | 7% |
| CRSP | CRISPR Therapeutics AG | 6.56% |
| PSNL | Personalis Inc | 6.19% |
| BEAM | Beam Therapeutics Inc | 4.34% |
| GH | Guardant Health Inc | 4.28% |
| NTRA | Natera Inc | 4.11% |
| ILMN | Illumina Inc | 3.98% |
About ARK Genomic Revolution ETF
The ARKG fund operates as an actively managed Exchange Traded Fund (ETF), aiming to achieve significant capital appreciation over an extended period. Its investment strategy involves committing a minimum of 80% of its total assets, under typical market conditions, to equity securities issued by both domestic and international companies. These companies are strategically chosen from various sectors based on their direct connection to the fund's core investment principle: the groundbreaking genomics revolution.